Cover Image

Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer

The estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) statuses are frequently discordant between the primary tumor and metastatic lesions in metastatic breast cancer. This can have important therapeutic implications.

Saved in:
Bibliographic Details
Main Authors: Walter, Vincent P. (Author) , Fischer, Chiara (Author) , Deutsch, Thomas M. (Author) , Ersing, Catherine (Author) , Nees, Juliane (Author) , Schütz, Florian (Author) , Fremd, Carlo (Author) , Grischke, Eva-Maria (Author) , Sinn, Peter (Author) , Brucker, Sara (Author) , Schneeweiss, Andreas (Author) , Hartkopf, Andreas (Author) , Wallwiener, Markus (Author)
Format: Article (Journal)
Language:English
Published: 01 July 2020
In: Breast cancer research and treatment
Year: 2020, Volume: 183, Issue: 1, Pages: 137-144
ISSN:1573-7217
DOI:10.1007/s10549-020-05746-8
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s10549-020-05746-8
Get full text
Author Notes:Vincent Walter, Chiara Fischer, Thomas M. Deutsch, Catherine Ersing, Juliane Nees, Florian Schütz, Carlo Fremd, Eva-Maria Grischke, Peter Sinn, Sara Y. Brucker, Andreas Schneeweiss, Andreas D. Hartkopf, Markus Wallwiener
Description
Summary:The estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) statuses are frequently discordant between the primary tumor and metastatic lesions in metastatic breast cancer. This can have important therapeutic implications.
Item Description:Gesehen am 08.12.2021
Physical Description:Online Resource
ISSN:1573-7217
DOI:10.1007/s10549-020-05746-8

Similar Items